Atara biotherapeutics to present at the 40th annual j.p. morgan healthcare conference

South san francisco, calif.--(business wire)--atara biotherapeutics, inc. (nasdaq: atra), a leader in t-cell immunotherapy, leveraging its novel allogeneic epstein-barr virus (ebv) t-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that pascal touchon, president and chief executive officer of atara, will present at the virtual 40th annual j.p. morgan healthcare conference on wednesday, january 12, 2022 at 2:15 pm pst / 5:15 pm e
ATRA Ratings Summary
ATRA Quant Ranking